5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 30.87▲ | 30.54▲ | 30.53▲ | 29.76▲ | 28.10▲ |
MA10 | 30.78▲ | 30.43▲ | 30.21▲ | 28.94▲ | 30.09▲ |
MA20 | 30.63▲ | 30.03▲ | 29.71▲ | 27.70▲ | 31.98▼ |
MA50 | 30.42▲ | 29.58▲ | 29.33▲ | 30.43▲ | 40.51▼ |
MA100 | 30.09▲ | 29.20▲ | 28.29▲ | 33.34▼ | 33.38▼ |
MA200 | 29.63▲ | 28.07▲ | 28.30▲ | 40.39▼ | 32.23▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.031▲ | 0.070▲ | 0.121▲ | 0.556▲ | -0.169▼ |
RSI | 64.064▲ | 65.227▲ | 70.178▲ | 59.936▲ | 43.636▼ |
STOCH | 86.131▲ | 77.168 | 90.189▲ | 84.936▲ | 29.453 |
WILL %R | -30.370 | -5.430▲ | -5.430▲ | -3.650▲ | -41.004 |
CCI | 147.096▲ | 127.228▲ | 123.810▲ | 101.213▲ | -38.356 |
Thursday, May 01, 2025 03:30 AM
U.S. Regulatory Filing Under Active Review for Approval of PYRUKYND® (mitapivat) in Thalassemia, with PDUFA Goal Date of September 7, 2025 – – Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease ...
|
Wednesday, April 30, 2025 11:01 AM
Analysts are estimating that Agios Pharmaceuticals will report an earnings per share (EPS) of $-1.76. The announcement from Agios Pharmaceuticals is eagerly anticipated, with investors seeking news of ...
|
Tuesday, April 29, 2025 04:59 PM
Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) last posted its quarterly earnings results on Thursday, February 20th.The biopharmaceutical company reported ($1.74) earnings per share (EPS ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 29.20 | 31.165 | 27.1859 | 30.94 | 597,497 |
30/04/25 | 28.95 | 30.06 | 28.28 | 29.69 | 686,582 |
29/04/25 | 29.55 | 29.56 | 28.94 | 29.09 | 366,483 |
28/04/25 | 29.75 | 30.29 | 29.23 | 29.62 | 530,594 |
25/04/25 | 29.04 | 29.88 | 28.70 | 29.45 | 358,865 |
24/04/25 | 28.30 | 29.30 | 28.04 | 29.26 | 378,770 |
23/04/25 | 28.82 | 29.22 | 28.32 | 28.37 | 405,019 |
22/04/25 | 27.79 | 28.24 | 27.49 | 28.00 | 387,481 |
21/04/25 | 27.38 | 28.02 | 26.915 | 27.34 | 680,865 |
17/04/25 | 27.11 | 28.3787 | 26.988 | 27.66 | 590,694 |
|
|
||||
|
|
||||
|
|